BIOMOTCPharmaceutical PreparationsFiscal year ends December 31
BIOMOLECULAR LIFE HOLDINGS, INC.
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 19, 2015
$0.79−0.02 (-2.47%)
Close on Oct 19, 2026
- Market cap
- $67.51M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Biomolecular Life has not reported a dividend
No dividend per share appears in Biomolecular Life's annual filings since fiscal 2012.